Logo-ipp

Immunopathol Persa. 2026;In Progress; 12(1): e43990. doi: 10.34172/ipp.2025.43990

Clinical Trial

Clinical outcomes of infliximab treatment in hospitalized patients with severe COVID-19; a parallel, double-blind, randomized controlled trial

Akbar Soleymani Babadi 1 ORCID, Mahdi Ghatrehsamani 2 ORCID, Jafar Majidi 2 ORCID, Soleiman Kheiri 3 ORCID, Mohammad Mousavi 1 * ORCID

Cited by CrossRef: